Financials
- Market Capitalization 195.76 M
- Employee 141
- Founded 2013
- CEO N/A
- Website www.voyagertherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG005ZSY233
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3630 | IMUX Immunic, Inc. - Common Stock | 14.64 USD | -0.88% | -1.61% | +4.87% | +1622.35% | 199.42 M USD | ||
| 3631 | NERV Minerva Neurosciences, Inc - Common Stock | 4.27 USD | -9.53% | -13.21% | -7.38% | +142.61% | 198.93 M USD | ||
| 3643 | KRRO Korro Bio, Inc. - Common Stock | 13.50 USD | -7.28% | -3.98% | +14.12% | -65.30% | 194.70 M USD | ||
| 3648 | PLX Protalix BioTherapeutics, Inc. Common Stock | 2.40 USD | -2.04% | +4.35% | +16.50% | -17.81% | 193.37 M USD |
Frequently asked questions about Voyager Therapeutics, Inc. - Common Stock
What is the Voyager Therapeutics, Inc. - Common Stock stock price today?
The current price of Voyager Therapeutics, Inc. - Common Stock (VYGR) is 3.24. Over the past 24 hours, the stock has changed by -5.81%. Follow the VYGR chart for real-time price dynamics.
What is the stock ticker of Voyager Therapeutics, Inc. - Common Stock?
Voyager Therapeutics, Inc. - Common Stock trades under the ticker VYGR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Voyager Therapeutics, Inc. - Common Stock stock going up?
VYGR has changed by -11.48% over the last week, -8.73% over the last month, and -30.32% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Voyager Therapeutics, Inc. - Common Stock net income for the last quarter?
Voyager Therapeutics, Inc. - Common Stock reported net income of -27.94 M for the last quarter. The previous quarter showed -27.43 M, which means net income changed by -1.86%.
How many employees does Voyager Therapeutics, Inc. - Common Stock have?
As of the latest available data, Voyager Therapeutics, Inc. - Common Stock has 141 employees. Workforce size can provide additional context about the company's scale and operations.
What is Voyager Therapeutics, Inc. - Common Stock EBITDA?
Voyager Therapeutics, Inc. - Common Stock EBITDA is -29.7 M, and its EBITDA margin is -1 145.51%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Voyager Therapeutics, Inc. - Common Stock stock?
You can buy Voyager Therapeutics, Inc. - Common Stock (VYGR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Voyager Therapeutics, Inc. - Common Stock stock?
Investing in Voyager Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VYGR chart and related analysis on metatrader.com as part of your research.